Alzheimers Dement

1. RISSMAN RA, Langford O, Raman R, Donohue MC, et al
   Plasma Abeta42/Abeta40 and phospho-tau217 concentration ratios increase the accuracy of amyloid PET classification in preclinical Alzheimer's disease.
   Alzheimers Dement. 2023 Nov 6. doi: 10.1002/alz.13542.
   

   >> Share

   
   

   
   Am J Geriatr Psychiatry

2. KERCKHOVE N, Bornier N, Mulliez A, Elyn A, et al
   Prevalence of Chronic Pain Among People with Dementia: A Nationwide Study Using French Administrative Data.
   Am J Geriatr Psychiatry. 2023;31:1149-1163.
   

   >> Share

   
   
3. LANCTOT KL, Rivet L, Tumati S, Perin J, et al
   Heterogeneity of Response to Methylphenidate in Apathetic Patients in the ADMET 2 Trial.
   Am J Geriatr Psychiatry. 2023;31:1077-1087.
   

   >> Share

   
   

   
   BMC Neurol

4. DIBELLO JR, Lu Y, Swartz J, Bortnichak EA, et al
   Patterns of use of symptomatic treatments for Alzheimer's disease dementia (AD).
   BMC Neurol. 2023;23:400.
   

   >> Share

   
   

   
   Brain

5. KORETSKY MJ, Alvarado C, Makarious MB, Vitale D, et al
   Genetic risk factor clustering within and across neurodegenerative diseases.
   Brain. 2023 May 16:awad161. doi: 10.1093.
   

   >> Share

   
   
6. RAMANAN VK, Gebre RK, Graff-Radford J, Hofrenning E, et al
   Genetic risk scores enhance the diagnostic value of plasma biomarkers of brain amyloidosis.
   Brain. 2023;146:4508-4519.
   

   >> Share

   
   
7. HAMPEL H, Elhage A, Cho M, Apostolova LG, et al
   Amyloid-related imaging abnormalities (ARIA): radiological, biological and clinical characteristics.
   Brain. 2023;146:4414-4424.
   

   >> Share

   
   
8. SILVA-RODRIGUEZ J, Labrador-Espinosa MA, Moscoso A, Scholl M, et al
   Characteristics of amnestic patients with hypometabolism patterns suggestive of Lewy body pathology.
   Brain. 2023;146:4520-4531.
   

   >> Share

   
   

   
   Brain Res

9. YU H, Morihara R, Ota-Elliott R, Bian Z, et al
   Injection of exogenous amyloid-beta oligomers aggravated cognitive deficits, and activated necroptosis, in APP23 transgenic mice.
   Brain Res. 2023;1821:148565.
   

   >> Share

   
   
10. YANG Y, Wang J, Ni H, Ding H, et al
    Genetic model of selective COX2 inhibition improve learning and memory ability and brain pathological changes in 5xFAD mouse.
    Brain Res. 2023;1821:148566.
    

    >> Share

    
    
11. MIAO J, Liu X, Lan J
    40 Hz Electroacupuncture relieves the memory dysfunction of 5xFAD mice by regulating neuronal electrical activity.
    Brain Res. 2023;1821:148576.
    

    >> Share

    
    

    
    J Alzheimers Dis

12. MANI S, Dubey R, Lai IC, Babu MA, et al
    Oxidative Stress and Natural Antioxidants: Back and Forth in the Neurological Mechanisms of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Nov 2. doi: 10.3233/JAD-220700.
    

    >> Share

    
    
13. FUJISAWA C, Umegaki H, Sugimoto T, Nakashima H, et al
    Relationship Between Non-Cognitive Intrinsic Capacity and Activities of Daily Living According to Alzheimer's Disease Stage.
    J Alzheimers Dis. 2023 Oct 30. doi: 10.3233/JAD-230786.
    

    >> Share

    
    
14. PERRON J, Scramstad C, Hyun Ko J
    Analysis of Costs for Imaging-Assisted Pharmaceutical Intervention in Alzheimer's Disease with Lecanemab: Snapshot of the First 3 Years.
    J Alzheimers Dis. 2023 Nov 1. doi: 10.3233/JAD-230633.
    

    >> Share

    
    
15. YANG J, Shi X, Wang Y, Ma M, et al
    Multi-Target Neuroprotection of Thiazolidinediones on Alzheimer's Disease via Neuroinflammation and Ferroptosis.
    J Alzheimers Dis. 2023 Oct 30. doi: 10.3233/JAD-230593.
    

    >> Share

    
    
16. SALHI L, Al Taep Y, Salmon E, Van Hede D, et al
    How Periodontitis or Periodontal Bacteria Can Influence Alzheimer's Disease Features? A Systematic Review of Pre-Clinical Studies.
    J Alzheimers Dis. 2023 Oct 30. doi: 10.3233/JAD-230478.
    

    >> Share

    
    

    
    J Neurochem

17. QIN H, Zhou L, Haque FT, Martin-Jimenez C, et al
    Diverse signaling mechanisms and heterogeneity of astrocyte reactivity in Alzheimer's disease.
    J Neurochem. 2023 Nov 6. doi: 10.1111/jnc.16002.
    

    >> Share

    
    

    
    J Neurol

18. CHAN E, Bonifacio GB, Harrison C, Banerjee G, et al
    Domain-specific neuropsychological investigation of CAA with and without intracerebral haemorrhage.
    J Neurol. 2023 Sep 6. doi: 10.1007/s00415-023-11977.
    

    >> Share

    
    

    
    N Engl J Med

19. 
    Alzheimer's Update, Part 1: ITT Episode 20.
    N Engl J Med. 2023;389:e33.
    

    >> Share

    
    

    
    Neurobiol Aging

20. KAN CN, Huang X, Zhang L, Hilal S, et al
    Comorbid amyloid with cerebrovascular disease in domain-specific cognitive and neuropsychiatric disturbances: a cross-sectional memory clinic study.
    Neurobiol Aging. 2023;132:47-55.
    

    >> Share

    
    
21. CATTERSON JH, Minkley L, Aspe S, Judd-Mole S, et al
    Protein retention in the endoplasmic reticulum rescues Abeta toxicity in Drosophila.
    Neurobiol Aging. 2023;132:154-174.
    

    >> Share

    
    
22. QIU T, Hong H, Zeng Q, Luo X, et al
    Degeneration of cholinergic white matter pathways and nucleus basalis of Meynert in individuals with objective subtle cognitive impairment.
    Neurobiol Aging. 2023;132:198-208.
    

    >> Share

    
    
23. LAN G, Du J, Chen X, Wang Q, et al
    Association of APOE-epsilon4 and GAP-43-related presynaptic loss with beta-amyloid, tau, neurodegeneration, and cognitive decline.
    Neurobiol Aging. 2023;132:209-219.
    

    >> Share

    
    

    
    Neurology

24. MALPETTI M, Rabinovici GD
    From Clinical Trials to Memory Clinics, tau-PET Visual Reads Can Help Diagnosis and Patient Stratification.
    Neurology. 2023 Sep 25:10.1212/WNL.0000000000207935.
    

    >> Share

    
    
25. HOWE MD, Rabinovici GD, Salloway SP
    Real-World Application of Anti-beta-Amyloid Monoclonal Antibodies: Untangling Eligibility.
    Neurology. 2023;101:811-812.
    

    >> Share

    
    
26. PITTOCK RR, Aakre JA, Castillo AM, Ramanan VK, et al
    Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging.
    Neurology. 2023;101:e1837-e1849.
    

    >> Share

    
    
27. ALAM JJ, Maruff P, Doctrow SR, Chu HM, et al
    Association of Plasma Phosphorylated Tau With the Response to Neflamapimod Treatment in Patients With Dementia With Lewy Bodies.
    Neurology. 2023;101:e1708-e1717.
    

    >> Share

    
    

    
    Neurosci Lett

28. GUO F, Kang J, Xu J, Wei S, et al
    Genome-wide identification of m(6)A-associated single nucleotide polymorphisms in complex diseases of nervous system.
    Neurosci Lett. 2023;817:137513.
    

    >> Share

    
    

    
    Neuroscience

29. WANG Q, Guo S, Hu D, Dong X, et al
    Enhanced GSDME-mediated pyroptosis in Alzheimer's disease.
    Neuroscience. 2023 Nov 7:S0306-4522(23)00491.
    

    >> Share

    
    

    
    PLoS One

30. MCCANN E, Lee S, Coleman F, O'Sullivan JD, et al
    Pareidolias are a function of visuoperceptual impairment.
    PLoS One. 2023;18:e0293942.
    

    >> Share

    
    

    
    Rev Neurol (Paris)

31. SINGLAS M, Tran THC, Boucenna W, Diouf M, et al
    Is internal retinal thickness an early marker of Alzheimer's and Lewy body diseases?
    Rev Neurol (Paris). 2023 Nov 2:S0035-3787(23)01081.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share